[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585967":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":21,"locations":27,"responsibleParty":113,"collaborators":10,"id":115,"slug":116,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":121,"eligibilityCriteria":122,"healthyVolunteers":117,"sex":123,"minAge":124,"maxAge":10,"enrollmentInfo":125,"targetDuration":10,"studyType":128,"phases":10,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"AstraZeneca","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ravulizumab",null,"Open-lable arm with gMG patients who received ravulizumab treatment in the frames of NDP in Poland.",[13],"Drug: Ravulizumab",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Ravulizumab, concentrate for solution for infusion",[9],[20],"Ultomiris",[22],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"AstraZeneca Clinical Study Information Center","CONTACT","1-877-240-9479","information.center@astrazeneca.com",[28,40,47,54,61,68,75,83,88,95,99,106],{"facility":29,"status":30,"city":31,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"Research Site","RECRUITING","Bydgoszcz","Poland","PL",{"type":35,"coordinates":36},"Point",[37,38],18.00762,53.1235,{"lat":38,"lon":37},{"facility":29,"status":30,"city":41,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":42,"geoPoint":46,"contacts":10},"Gdansk",{"type":35,"coordinates":43},[44,45],18.64912,54.35227,{"lat":45,"lon":44},{"facility":29,"status":30,"city":48,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":49,"geoPoint":53,"contacts":10},"Katowice",{"type":35,"coordinates":50},[51,52],19.02173,50.2597,{"lat":52,"lon":51},{"facility":29,"status":30,"city":55,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":56,"geoPoint":60,"contacts":10},"Krakow",{"type":35,"coordinates":57},[58,59],19.93658,50.06143,{"lat":59,"lon":58},{"facility":29,"status":30,"city":62,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":63,"geoPoint":67,"contacts":10},"Lodz",{"type":35,"coordinates":64},[65,66],19.47395,51.77058,{"lat":66,"lon":65},{"facility":29,"status":30,"city":69,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":70,"geoPoint":74,"contacts":10},"Lublin",{"type":35,"coordinates":71},[72,73],22.57009,51.25058,{"lat":73,"lon":72},{"facility":29,"status":76,"city":77,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":78,"geoPoint":82,"contacts":10},"WITHDRAWN","Poznan",{"type":35,"coordinates":79},[80,81],16.92993,52.40692,{"lat":81,"lon":80},{"facility":29,"status":84,"city":77,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":85,"geoPoint":87,"contacts":10},"NOT_YET_RECRUITING",{"type":35,"coordinates":86},[80,81],{"lat":81,"lon":80},{"facility":29,"status":30,"city":89,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":90,"geoPoint":94,"contacts":10},"Szczecin",{"type":35,"coordinates":91},[92,93],14.55302,53.42894,{"lat":93,"lon":92},{"facility":29,"status":84,"city":89,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":96,"geoPoint":98,"contacts":10},{"type":35,"coordinates":97},[92,93],{"lat":93,"lon":92},{"facility":29,"status":30,"city":100,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":101,"geoPoint":105,"contacts":10},"Warsaw",{"type":35,"coordinates":102},[103,104],21.01178,52.22977,{"lat":104,"lon":103},{"facility":29,"status":30,"city":107,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":108,"geoPoint":112,"contacts":10},"Wroclaw",{"type":35,"coordinates":109},[110,111],17.03006,51.10286,{"lat":111,"lon":110},{"type":114,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100585967","ravulizumab-treatment-outcomes-in-patients-with-generalized-myasthenia-gravis-100585967",false,"NCT06909253","Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis","Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis (gMG) Naive to Complement Inhibitors. Prospective, Multicenter, Non-interventional Study (MG-ARCADIA).","MG-ARCADIA","Inclusion Criteria:\n\n* Adult (aged ≥18 years) patients with gMG, naive to complement inhibitors, receiving ravulizumab treatment in the frames of NDP in Poland.\n* Patients willing to participate in the study and signed Informed Consent Form (ICF).\n* Vaccination against N. meningitidis\n\nExclusion Criteria:\n\n* Those who plan to participate in gMG clinical trial on\u002Fafter the date of first ravulizumab infusion through NDP.\n* Cognitive incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.","ALL","18 Years",{"count":126,"type":127},50,"ESTIMATED","OBSERVATIONAL","The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.",[131],"Myasthenia Gravis, Generalized",[9,133,134,135],"Generalized Myasthenia Gravis","gMG","observational","2026-06-17",{"date":138,"type":139},"2026-06-18","ACTUAL",{"date":141,"type":139},"2025-05-15",{"date":143,"type":127},"2029-12-31",{"name":5,"class":6},12]